SEC Form 4 · accession 0001627223-18-000031
Chemours Co · CC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Newman
Officer — SVP and CFO
Period of report
May 8, 2018
Accepted (ET)
May 10, 2018 · 9:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001627223
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 8, 2018 | M | 40,000 | $18.45 | A | 125,399 | D | |
| Common Stock | May 8, 2018 | S | 40,000 | $50.00 | D | 85,399 | D | |
| Common StockF2,F3 | May 8, 2018 | S | 3,675 | $50.45 | D | 81,724 | D | |
| Common Stock | holding | — | — | — | 2,480 | I | Reporting person's children |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $18.45 | May 8, 2018 | M | 40,000 | D | — | Feb 3, 2022 | Common Stock | 40,000 | 67,675 | D |
Explanation of responses
- F1The stock option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018.
- F2Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $50.00 to $50.81.
- F3Includes restricted stock units and dividend equivalent units.
- F4Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.